VELCADE® (bortezomib) for Injection is indicated for the treatment of patients with multiple myeloma. VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol.
Your doctor may have recommended VELCADE to treat multiple myeloma. This website offers resources that may help answer some of your questions, or those of your family or caregivers, about VELCADE therapy.
The information contained here is not intended to replace conversation with a healthcare professional. Always seek the advice of a qualified healthcare professional before starting any new treatment or with any questions you may have about a medical condition.
Please CLICK HERE to view important safety information.
For full Prescribing Information CLICK HERE.
For further information about VELCADE® (bortezomib) for Injection,
call 1-866-VELCADE (U.S. clinicians only).
|
